Uptake of COVID-19 and influenza vaccines in relation to preexisting chronic conditions in the European countries

被引:5
作者
Tang, Shangfeng [1 ]
Ji, Lu [1 ]
Bishwajit, Ghose [2 ]
Guo, Shuyan [3 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Med & Hlth Management, Wuhan, Peoples R China
[2] Univ Ottawa, Fac Hlth Sci, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada
[3] Natl Hlth Commiss, Natl Inst Hosp Adm, Beijing, Peoples R China
关键词
COVID-19; Influenza; Vaccine; Chronic disease; Comorbidities; Vaccine hesitancy; VACCINATION; HESITANCY; DISEASE;
D O I
10.1186/s12877-023-04623-5
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
BackgroundThe suboptimal uptake of COVID-19 and influenza vaccines among those with non-communicable chronic diseases is a public health concern, because it poses a higher risk of severe illness for individuals with underlying health conditions, emphasizing the need to address barriers to vaccination and ensure adequate protection for this vulnerable population. In the present study, we aimed to identify whether people with chronic illnesses are more likely to get vaccinated against COVID-19 and influenza in the European Union.MethodsCross-sectional data on 49,253 men (n = 20,569) and women (n = 28,684) were obtained from the ninth round of the Survey of Health, Ageing and Retirement in Europe (June - August, 2021). The outcome variables were self-reported COVID-19 and influenza vaccine uptake status. The association between the uptake of the vaccines and six preexisting conditions including high blood pressure, high blood cholesterol, chronic lung disease, diabetes, chronic bronchitis, and asthma was estimated using binary logistic regression methods.ResultsThe vaccination coverage for COVID-19 ranged from close to 100% in Denmark (98.2%) and Malta (98.2%) to less than 50% in Bulgaria (19.1%) and Romania (32.7%). The countries with the highest percentage of participants with the influenza vaccine included Malta (66.7%), Spain (63.7%) and the Netherlands (62.5%), and those with the lowest percentage included Bulgaria (3.7%), Slovakia (5.8%) and Poland (9.2%). Participants with high blood pressure were 3% less likely [Risk difference (RD) = -0.03, 95% CI = -0.04, -0.03] to report taking COVID-19 and influenza [RD = -0.03, 95% CI= -0.04, -0.01] vaccine. Those with chronic lung disease were 4% less likely [RD = -0.04, 95% CI= -0.06, -0.03] to report taking COVID-19 and 2% less likely [RD= -0.02, 95% CI = -0.04, -0.01] to report taking influenza vaccine. Men and women with high blood pressure were 3% less likely to have reported taking both of the vaccines.ConclusionsCurrent findings indicate a suboptimal uptake of COVID-19 and influenza vaccines among adult men and women in the EU countries. Those with preexisting conditions, including high blood pressure and chronic lung disease are less likely to take the vaccines.
引用
收藏
页数:8
相关论文
共 31 条
  • [1] Asadi-Pooya AA, Disaster Med Public Health Prep., P1
  • [2] COVID-19 Vaccine Hesitancy in Patients on Dialysis in Italy and France
    Blanchi, Sophie
    Torreggiani, Massimo
    Chatrenet, Antoine
    Fois, Antioco
    Maze, Beatrice
    Njandjo, Linda
    Bianco, Giovanna
    Lepori, Nicola
    Pili, Alessio
    Michel, Pierre-Antoine
    Sileno, Giuseppe
    Arazzi, Marta
    Esposito, Vittoria
    Pani, Antonello
    Versino, Elisabetta
    Esposito, Ciro
    Fessi, Hafedh
    Cabiddu, Gianfranca
    Piccoli, Giorgina Barbara
    [J]. KIDNEY INTERNATIONAL REPORTS, 2021, 6 (11): : 2763 - 2774
  • [3] Double threat of COVID-19 and influenza
    Burki, Talha Khan
    [J]. LANCET RESPIRATORY MEDICINE, 2020, 8 (12) : E97 - E97
  • [4] Coronavirus: Why Men are More Vulnerable to Covid-19 Than Women?
    George M. Bwire
    [J]. SN Comprehensive Clinical Medicine, 2020, 2 (7) : 874 - 876
  • [5] Projecting the Combined Health Care Burden of Seasonal Influenza and COVID-19 in the 2020-2021 Season
    Du, Zhanwei
    Fox, Spencer J.
    Ingle, Tanvi
    Pignone, Michael P.
    Meyers, Lauren Ancel
    [J]. MDM POLICY & PRACTICE, 2022, 7 (01)
  • [6] Fabiao J, 2022, BRAZ J MED BIOL RES, V55, DOI [10.1590/1414-431X2021e11711, 10.1590/1414-431x2021e11711]
  • [7] Prevalence of influenza and pneumococcal vaccination in chronic obstructive pulmonary disease patients in association with the occurrence of acute exacerbations
    Fekete, Monika
    Pako, Judit
    Nemeth, Anna N.
    Tarantini, Stefano
    Varga, Janos Tamas
    [J]. JOURNAL OF THORACIC DISEASE, 2020, 12 (08) : 4233 - 4242
  • [8] Influenza vaccine effectiveness in reducing severe outcomes over six influenza seasons, a case-case analysis, Spain, 2010/11 to 2015/16
    Godoy, Pere
    Romero, Arantxa
    Soldevila, Nuria
    Torner, Nuria
    Jane, Mirela
    Martinez, Ana
    Cayla, Joan A.
    Rius, Cristina
    Dominguez, Angela
    [J]. EUROSURVEILLANCE, 2018, 23 (43): : 13 - 21
  • [9] The ratio of older women to men: Historical perspectives and cross-national comparisons
    Guralnik, JM
    Balfour, JL
    Volpato, S
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2000, 12 (02) : 65 - 76
  • [10] Short communication Conditionality of COVID-19 vaccine acceptance in European countries
    Heyerdahl, Leonardo W.
    Vray, Muriel
    Lana, Benedetta
    Tvardik, Nastassia
    Gobat, Nina
    Wanat, Marta
    Tonkin-Crine, Sarah
    Anthierens, Sibyl
    Goossens, Herman
    Giles-Vernick, Tamara
    [J]. VACCINE, 2022, 40 (09) : 1191 - 1197